Search research articles
Contact Us
Filters
Showing results (11-20 of 157) with videos related to
Page
of 16
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 23, 2017
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
Guo-Xiang Ruan, Elizabeth Barry, Dan Yu, et al.
Neuro-Degenerative Diseases
|
February 14, 2012
Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models
S Pablo Sardi, Priyanka Singh, Seng H Cheng, et al.
Human Molecular Genetics
|
September 24, 2013
Reversibility of neuropathology in Tay-Sachs-related diseases
María-Begoña Cachón-González, Susan Z Wang, Robin Ziegler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2004
Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors
Hongmei Zhao, Hiraoki Hemmi, Shizuo Akira, et al.
Plos One
|
April 20, 2012
Proteasome inhibition is partially effective in attenuating pre-existing immunity against recombinant adeno-associated viral vectors
Jozsef Karman, Nathan K Gumlaw, Jinhua Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 29, 2009
AAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function
Makiko Yasuda, David F Bishop, Mary Fowkes, et al.
The Journal of Gene Medicine
|
March 14, 2007
Identification of transfected cell types following non-viral gene transfer to the murine lung
Lee A Davies, Claire Seguela, Anusha Varathalingam, et al.
The Journal of Gene Medicine
|
July 27, 2007
Acute intermittent porphyria: vector optimization for gene therapy
Makiko Yasuda, Maciej E Domaradzki, Donna Armentano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2006
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
M Begoña Cachón-González, Susan Z Wang, Andrew Lynch, et al.
Human Gene Therapy
|
March 18, 2003
DNA sequences in cationic lipid:pDNA-mediated systemic toxicities
Jennifer D Tousignant, Hongmei Zhao, Nelson S Yew, et al.
Page
of 16
Search research articles
Search
Showing results (11-20 of 157) with videos related to
Sort By:
Page
of 16
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 23, 2017
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
Guo-Xiang Ruan, Elizabeth Barry, Dan Yu, et al.
Neuro-Degenerative Diseases
|
February 14, 2012
Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models
S Pablo Sardi, Priyanka Singh, Seng H Cheng, et al.
Human Molecular Genetics
|
September 24, 2013
Reversibility of neuropathology in Tay-Sachs-related diseases
María-Begoña Cachón-González, Susan Z Wang, Robin Ziegler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2004
Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors
Hongmei Zhao, Hiraoki Hemmi, Shizuo Akira, et al.
Plos One
|
April 20, 2012
Proteasome inhibition is partially effective in attenuating pre-existing immunity against recombinant adeno-associated viral vectors
Jozsef Karman, Nathan K Gumlaw, Jinhua Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 29, 2009
AAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function
Makiko Yasuda, David F Bishop, Mary Fowkes, et al.
The Journal of Gene Medicine
|
March 14, 2007
Identification of transfected cell types following non-viral gene transfer to the murine lung
Lee A Davies, Claire Seguela, Anusha Varathalingam, et al.
The Journal of Gene Medicine
|
July 27, 2007
Acute intermittent porphyria: vector optimization for gene therapy
Makiko Yasuda, Maciej E Domaradzki, Donna Armentano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2006
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
M Begoña Cachón-González, Susan Z Wang, Andrew Lynch, et al.
Human Gene Therapy
|
March 18, 2003
DNA sequences in cationic lipid:pDNA-mediated systemic toxicities
Jennifer D Tousignant, Hongmei Zhao, Nelson S Yew, et al.
Page
of 16